IRON SUPPLEMENTATION Iron is an essential constituent of the body; necessary for hemoglobin formation and oxidative processes of living tissues. Iron deficiency.

Slides:



Advertisements
Similar presentations
Development of ARV FDC for Pediatric use Alan Parr, Pharm.D., Ph.D. GlaxoSmithKline Research Triangle Park, NC.
Advertisements

Biochemical Tests By Cheryl Kent.
Training Workshop on Pharmaceutical Development with a Focus on Paediatric Medicines / October |1 | Training Workshop on Pharmaceutical Development.
2-5. Formulation Development Issues: Solid Orals Satish Mallya January, 2011.
1st lecture MSc. Ikhlas Jarrar
Iron deficiency Anemia :- Deficiency in number of redblood cells or deficiency in total hemoglobin content per unit of blood volum. Anemia can be caused.
Asthma  Most common chronic illness of childhood, affecting approximately 10% children.  Available preventive therapies for persistent asthma include.
Department of Pharmacetical Chemistry, College of Pharmacy, Salman Bin Abdulaziz University, Al-Kharj, Saudi Arabia  Gastric region is one of the main.
DRUG DOSAGE FORMS Dr.Abdul Latif Mahesar.
Determine impurity level in relevant batches1
Applied Water and Spent water Manual Chapter 14
In your culinary journal:
Pharmaceutical Excipients
Interchangeability and study design Drs. Jan Welink Training workshop: Training of BE assessors, Kiev, October 2009.
Iron and Manganese Removal
CHAPTER 8 ACIDS & BASES. IDENTIFYING ACIDS A. IDENTIFYING ACIDS A. AN ACID IS A COMPOUND THAT PRODUCES HYDRONIUM IONS (H 3 O + ) WHEN DISSOLVED IN WATER.
Baking & Dough In your culinary journal: 1.What do you feel is something that is very important to know/remember when baking? 2.What are some types of.
Factors Affecting Drug Absorption (Pharmaceutical factor)
© NextPharma Technologies 2006 NextPharma Technologies Experts in the production of Pellets.
CHAPTER 12 ELECTRODE POTENTIALS AND THEIR APPLICATIONS TO XIDATION/REDUCTION TITRATIONS Introduction to Analytical Chemistry.
PHARMACEUTICS- IV (PHT 414 ) Dr. Shahid Jamil SALMAN BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY L /9/2015 Factors Affecting Drug Absorption (Dosage.
Novel Multifunctional Excipients by Co-processing with Mg-Silicate Dr. Faisal Al-Akayleh Faculty of Pharmacy, Petra University.
Wellsville High School PE 901
Formulation factors By Dr. A. S. Adebayo.
1 Suspension 1. 2  Suspension:  Suspension: A suspension is a two-phase system consisting of a finely divided solid particles dispersed in liquid, or.
<701> DISINTEGRATION
Determination of blood glucose Done by: Sahar Al-Subaie.
An Introduction to Acids & Bases VCE Chemistry Unit 2: Environmental Chemistry Area of Study 1 – Water.
CHEE 4401 CAPSULES u solid dosage form u the drug is enclosed within either a hard or soft shell ä shell is typically made of gelatin u primarily intended.
Formulation, Characterization of Pellets of Duloxetine Hydrochloride by Extrusion and Spheronization Prof. V. R. Sinha University Institute of Pharmaceutical.
1 G&H Meeting 4-5 th October, 2001 G&H Meeting 4-5 th October, 2001 Wellesbourne, UK Wellesbourne, UK WP 7 Pharmaceutics WP 7 Pharmaceutics Objectives.
Introduction What is a Biowaiver?
Solid dosage forms Tablets
Advantages and disadvantages of solutions
PRECIPITIMETRIC TITRATIONS
Development and Assessment of Captopril Loaded Matrix-Type Pellets Roderick B. Walker 1, Sandile M.M. Khamanga and Samantha Y. Mukozhiwa Faculty of Pharmacy,
TABLET GRANULATION TECHNIQUES.
DRY SYRUPS.
content’s  Definition  Significance  Requirements of FDT  Formulation methodologies  Patented technologies  Potential candidates for FDT  Survey.
Formulations of Aspirin TP n°7. Experimental setup : a. Grind the aspirin pill in a mortar, then pour some ethanol in order to dissolve the pill. b. Filter.
Solid Dosage Forms - tablets
- Pharmaceutical Equivalence Study
Patentability of Product Based on Dissolution Data
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
Introduction What is a Biowaiver?
Solid dosage forms Tablets
Gastrointestinal Absorption: Role of the Dosage Form
Capsule: A small container
Biopharmaceutic Considerations in Drug Product Design
IPSA (Industrial Problem Solving Ability )
Factors Affecting Drug Absorption (Dosage form factor)
Assay & Identification of Acetaminophen
FARHANA AMIRAH NADIA AMIR
J.Preethi*, P. Madhu, K. Arshad Ahmed Khan.
Lab -7- Capsules.
Learning Objectives Acids and Alkalis
Tablet Dosage Form Lab 1.
Analysis of antacid By titration
Solutions, Acids, Bases & pH
Selected Calculations in Contemporary Compounding
Lab -7- Capsules.
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
Lab. 2 Industrial pharmacy
RingCap Technology Mrs. Maria Saifee Associate Professor,
Formulation factors By Dr. A. S. Adebayo.
University of sulaimani
Acceptability aspects: Taste, odour and appearance  Water should be free of tastes and odours that would be objectionable to the majority of consumers.
Tablets.
Fenofibrate USP (Micronized, control)
Presentation transcript:

IRON SUPPLEMENTATION Iron is an essential constituent of the body; necessary for hemoglobin formation and oxidative processes of living tissues. Iron deficiency is the most common nutritional disorder in the world. Approximately 25% of the world’s population is iron deficient. Studies have indicated that iron supplementation may increase cognitive skills in children and adolescents with iron deficiency. The major activity of supplemental iron is in the prevention and treatment of iron deficiency anemia. A number of ferrous and ferric salts are available for the same. However, the compliance with iron salts is poor, mainly because of the associated metallic taste. Iron in ferrous state is more readily absorbed by the body than in ferric state.

COMPLIANCE OF MEDICINES IN PEDIATRICS  Taste is a major consideration when designing a pediatric compliant dosage form.  ‘Melt in Mouth’ solid dosage forms encompass the advantages of solid and liquid dosage forms. ‘Melt in Mouth’ pellets or ‘Meltlets’ are : A novel and an innovative extension of ‘Melt in mouth’ solid dosage forms Fast dissolving; when placed in mouth Pleasant tasting, flavored Unit dosage form, packed in sachets and can be directly emptied in the child’s mouth Can be used for administering high dose drugs

‘MELT IN MOUTH’ DOSAGE FORMS ARE A NOVEL AND AN INNOVATIVE DOSAGE FORM AND ARE EXPECTED TO IMPROVE THE ACCEPTANCE OF MEDICINES BY PEDIATRIC POPULATION OBJECTIVES OF THE INVESTIGATION  Formulation of palatable ‘Melt in Mouth’ pellets of Ferrous fumarate that would improve the compliance of the same in pediatrics.  Development of analytical technique for Ferrous fumarate  Exploiting ‘Extrusion – Spheronization’, as a technique for formulating the Melt in mouth pellets. This technique has been explored only for the formulation of immediate and controlled release pellets.

MATERIALS USED IN THE STUDY Ferrous fumarate Sweetener Novel channelizing agent Instacoat Flavor * Lemon Lime Flavor Novel Disintegrant Diluents Spheronization aid Flow enhancer * Instacoat Flavor is a blend of color, flavor and a cellulosic polymer. This is added as an excipient to mask the metallic taste of iron salt and to increase the palatibility and aesthetic appeal of the formulation.

EQUIPMENTS USED IN THE STUDY : Extruder E – 65 (R. R. Enterprises) Spheronizer S – 120 (R. R. Enterprises) Drying Oven (Expo, EIC – IA) IN – VITRO DISSOLUTION STUDIES: USP Type II, 75 rpm, 900 ml Dissolution Medium Dissolution Medium : USP pH 1.2 Hydrochloride Acid Buffer containing 0.5% w/v Sodium Lauryl Sulfate

OPTIMIZATION OF EXTRUSION - SPHERONIZATION  Extrusion was optimized for :  Extruder speed  Extruder screen size  Spheronization was optimised for :  Spheronization speed  Spheronization dwell time  Formulation optimization :  Ratio of Diluents  Quantity of granulating medium  Drying Time  Quantity of Instacoat Flavor, Lemon flavor and disintegrant

FORMULATION OF THE ‘MELT IN MOUTH’ PELLETS Channelizing Agent POWDER BLEND Granulation Extrude (Extrude E – 65) Spheronize (Spheronizer S – 160) Dry in oven for 4 hours at 60C and fractionate (16/20 #), Add Talc Fill in sachets Flavour (I) Instacoat Flavour (II) Cellulose Derivative Diluent Drug Sweetener Disintegrant

The formulated pellets were evaluated by a panel of 10 human volunteers and the results are as indicated : MELT IN MOUTH PELLETS (I) IIIIIIIVVVIVIIVIIIIXX Taste Mouthfeel Sweetness Flavor Disintegration Aftertaste--Slight Volunteers Parameter - None ++ Good + Ok +++Excellent

The formulated pellets were evaluated by a panel of 10 human volunteers and the results are as indicated : MELT IN MOUTH PELLETS (II) IIIIIIIVVVIVIIVIIIIXX Taste+++ Mouthfeel Sweetness Flavor Disintegration Aftertaste Volunteers Parameter - None ++ Good + Ok +++Excellent

ANALYTICAL METHOD DEVELOPMENT  TITRIMETRY : (As per Indian Pharmacopoeia 1996) For drug content as well as stability indicating assay. Analysis of Ferrous Iron : Titrant : Ceric Ammonium Sulfate VS Indicator : Ferroin End Point : Red to pale blue Standardized against : Sodium Thiosulphate Analysis of Ferric iron: Titrant : Sodium Thiosulphate VS Indicator : Starch solution End Point : Blue to colourless Standardized against : Potassium bromate

 COLORIMETRY: For drug content and analysis of drug in an in vitro release study. Principle : Iron forms a red colored complex with Thioglycollic acid in the presence of citric acid and at an alkaline pH.